AOD-9604

Also known as: hGH Fragment 176-191

Overview

AOD-9604 is a fragment of human growth hormone designed to promote fat loss without the side effects of hGH. It helps break down fat, reduces fat storage, and supports bone and cartilage health, making it potentially beneficial for weight management and joint repair. AOD-9604 is a modified fragment (176–191) of human growth hormone (hGH), engineered to harness the fat-burning capabilities of hGH without its adverse effects. It acts as a dual-action peptide, stimulating lipolysis (fat breakdown) and inhibiting lipogenesis (fat accumulation). In some clinical studies, AOD has displayed superior inhibition of fat production and promotion of fat breakdown than growth hormone. Frag 176-191 is a derivative of AOD, but lacks the disulfide bond, making it less stable and effective.

Benefits

- Reduces body fat and regulates fat metabolism

- Does not compete with growth hormone receptors

- Mimics natural growth hormone regulation

- Bone strengthening and cartilage repair

- Potential osteoarthritis relief

Consider This Peptide If You Want To

- Promote fat loss by stimulating fat breakdown and reducing fat storage without the side effects of full hGH

- Support joint and cartilage health for recovery or improved mobility

Dosage & Administration

Dosage Guidelines

Recommended Dosage

• Amount: 250 mcg

• Frequency: daily

• Duration: 6 weeks

• Rest Period: 2 week

• Time of Day: morning

• Ingestion: subcutaneous

Administration Routes:

- Subcutaneous

Research Findings on Dosage:

1. Subcutaneous Injection:

• Commonly Reported Dosage: 300 mcg once daily or 250 mcg twice daily (best taken on an empty stomach in the morning or before a workout to maximize fat burning)

• Duration: 6 week - 6 month cycles with 2 week break

Mechanism of Action

How this peptide works in the body

Fat Metabolism Activation:

• AOD-9604 stimulates hormone-sensitive lipase (HSL), an enzyme responsible for lipolysis (fat breakdown), by mimicking the fat-reducing actions of human growth hormone (hGH). This activation increases free fatty acid release from adipose tissue, allowing stored fat to be used for energy.

Inhibition of Fat Storage:

• By suppressing lipoprotein lipase (LPL) activity, AOD-9604 prevents the uptake and storage of triglycerides in adipose tissue. This inhibition reduces lipogenesis (fat accumulation), helping maintain a negative fat balance, particularly in visceral and subcutaneous fat deposits.

β-Adrenergic Receptor Efficiency:

• AOD-9604 enhances β-adrenergic receptor activation, improving catecholamine sensitivity in adipocytes, which boosts thermogenesis and metabolic rate. This effect increases energy expenditure, further supporting fat loss without altering growth hormone levels.

Bone Strengthening:

• AOD-9604 stimulates mesenchymal stem cells (MSCs) to undergo osteogenic differentiation, increasing bone mineralization and density. This occurs through the upregulation of bone morphogenetic proteins (BMPs) and alkaline phosphatase (ALP), which are essential for bone formation.

Cartilage Repair:

• By promoting chondrocyte proliferation and extracellular matrix production, AOD-9604 enhances collagen and proteoglycan synthesis, essential for cartilage strength and flexibility. This regenerative effect may aid in osteoarthritis relief and joint repair by preserving cartilage integrity.

Consider Stacking With

- Any GHRP (Ipamorelin, Hexarelin)

- Any GHRH (CJC-1295, MOD-GRF-129, Tesamorelin)

- BPC-157

- Kisspeptin-10

- TB-500

- Semaglutide/Tirzepatide

- IGF-LR3

- MOTS-c

- 5-Amino-1MQ

Side Effects & Cautions

Common Side Effects

- Mild redness, swelling, or discomfort at the injection site

Cautions

- Less effective in obese populations

Rare Side Effects

- Erythema, rash

Research & References

Research Highlights

1. Safety and Tolerability of AOD9604 in Humans (2013): Demonstrated no significant adverse effects or impact on IGF-1 levels, confirming AOD-9604's distinct action from hGH.

2. Lipid Metabolism in Obese Mice (2001): Showed AOD-9604's effectiveness in stimulating fat loss through enhanced β3-adrenergic receptor activity.

3. Applications in Osteoarthritis (Recent): Highlighted AOD-9604 + HA's potential in promoting cartilage regeneration and chondrocyte activity.

References

• Safety and Metabolism of AOD9604 (2014): Chronic use in animal studies confirmed safety and effective fat metabolism regulation

• Central and Peripheral Molecular Targets for Anti-Obesity Pharmacotherapy (2011): Explored the mechanisms and potential of AOD-9604 in obesity treatment

• The Effects of AOD9604 on Cartilage and Bone Repair (Recent): Demonstrated efficacy in cartilage regeneration and joint health improvement